首页 > 最新文献

Indo Global Journal of Pharmaceutical Sciences最新文献

英文 中文
In Sighting Role of Ashwagandha: Pharmacological Review 印度烟在视觉中的作用:药理研究进展
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s43
Hardeep Singh, Pooja Sharma, Dinesh Kumar
Withania somnifera (Solanaceae), commonly known as Ashwagandha is an important medicinal plant that has been used in Ayurvedic medicines for more than 3,000 years. It is specially used for the treatment of nervous and sexual disorders. The chief active chemical constituents are withanolides, withaferin A, withaniferin B, withanine, somniferine, somnine, sitoindoside. Withanolides are used in the treatment of arthritis and are shown to be potent inhibition of the activation of NF-kB. Withanone protects against the cerebral damage. It also exhibits antioxidant effects by increasing the antioxidant enzymes. Sitoindosides enhance the M1 and M2 muscarinic receptor binding to alter the AChE activity. Withania somnifera also showed significance protection against stress induced gastric ulcers. Withania somnifera showed a wide range of therapeutic activities and maintaining general health such as Immunomodulation, anti-cancer and anti-epileptic, memory enhancer, to promote good physical and mental health, mood elevator, diuretic, general tonic and rejuvenator, stress reliever, anti-ageing, anti-oxidant, hypoglycemic, hypocholesterolemic. Withanolides have got analgesic and anti-inflammatory activity due to cyclooxygenase-2 inhibition property. Ashwagandha enhances nitric oxide synthase activity of the macrophages, which in turn increases the microbial killing power of these immune cells thereby enhancing the Cell Mediated Immune (CMI) response. This plant is used due to its wide range of therapeutic activities and lesser side effects as compare to synthetic drugs. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Singh, H.; Sharma, P.; Kumar, D. In Sighting Role of Ashwagandha: Pharmacological Review. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 145. DOI: http://doi.org/10.35652/IGJPS.2019.92S43 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
Withania somnifera(茄科),俗称Ashwagandha,是一种重要的药用植物,已经在印度草药中使用了3000多年。它是专门用于治疗神经和性功能障碍。其主要有效化学成分为金菊内酯、金菊素A、金菊素B、金菊氨酸、金菊素、金菊苷。Withanolides被用于关节炎的治疗,并被证明是NF-kB激活的有效抑制。Withanone可以防止大脑损伤。它还通过增加抗氧化酶表现出抗氧化作用。西藤皂苷增强M1和M2毒蕈碱受体结合,改变乙酰胆碱酯酶活性。苦参对应激性胃溃疡也有显著的保护作用。somnifera显示出广泛的治疗活动和维持一般健康,如免疫调节,抗癌和抗癫痫,增强记忆,促进良好的身心健康,情绪升降机,利尿剂,一般滋补和恢复活力,缓解压力,抗衰老,抗氧化,降血糖,降胆固醇。由于对环氧合酶-2的抑制作用,其具有镇痛和抗炎作用。Ashwagandha可增强巨噬细胞的一氧化氮合酶活性,进而增强这些免疫细胞的微生物杀伤能力,从而增强细胞介导免疫(CMI)反应。与合成药物相比,这种植物因其广泛的治疗活性和较小的副作用而被使用。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:Singh, H.;沙玛,p;Kumar, D. Ashwagandha在视觉中的作用:药理综述。印度国际制药公司。科学。, 2019;9(2生理):145。DOI: http://doi.org/10.35652/IGJPS.2019.92S43。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE期刊列表,EMBASE(爱思唯尔),国家医学图书馆(NLM)目录,ResearchGate, Publons, CAS (ACS), Index Copernicus,谷歌Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
{"title":"In Sighting Role of Ashwagandha: Pharmacological Review","authors":"Hardeep Singh, Pooja Sharma, Dinesh Kumar","doi":"10.35652/igjps.2019.92s43","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s43","url":null,"abstract":"Withania somnifera (Solanaceae), commonly known as Ashwagandha is an important medicinal plant that has been used in Ayurvedic medicines for more than 3,000 years. It is specially used for the treatment of nervous and sexual disorders. The chief active chemical constituents are withanolides, withaferin A, withaniferin B, withanine, somniferine, somnine, sitoindoside. Withanolides are used in the treatment of arthritis and are shown to be potent inhibition of the activation of NF-kB. Withanone protects against the cerebral damage. It also exhibits antioxidant effects by increasing the antioxidant enzymes. Sitoindosides enhance the M1 and M2 muscarinic receptor binding to alter the AChE activity. Withania somnifera also showed significance protection against stress induced gastric ulcers. Withania somnifera showed a wide range of therapeutic activities and maintaining general health such as Immunomodulation, anti-cancer and anti-epileptic, memory enhancer, to promote good physical and mental health, mood elevator, diuretic, general tonic and rejuvenator, stress reliever, anti-ageing, anti-oxidant, hypoglycemic, hypocholesterolemic. Withanolides have got analgesic and anti-inflammatory activity due to cyclooxygenase-2 inhibition property. Ashwagandha enhances nitric oxide synthase activity of the macrophages, which in turn increases the microbial killing power of these immune cells thereby enhancing the Cell Mediated Immune (CMI) response. This plant is used due to its wide range of therapeutic activities and lesser side effects as compare to synthetic drugs. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Singh, H.; Sharma, P.; Kumar, D. In Sighting Role of Ashwagandha: Pharmacological Review. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 145. DOI: http://doi.org/10.35652/IGJPS.2019.92S43 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"64 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86881132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Therapy for the Treatment of Depression 一种治疗抑郁症的新疗法
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s36
Jyoti, Pooja Sharma, Dinesh Kumar
Depression is a mood disorder characterized by persistently low mood and a feeling of sadness and loss of interest. In all over the world 300 million peoples are suffered with depression to the world health organization. 16.2 million adults in the united states. Although conventional antidepressant therapy can help relieve symptoms of depression and prevent relapse of the illness, complementary therapies are required due to disadvantage of the current therapy such as adverse effects. Thus, it is worthwhile to look for antidepressant from plants with proven advantage and favorable benefit to risk ratio. A number of medicinal plants and medicine derived from these plants have shown antidepressant properties by virtue of combined effect of their medicinal constituents. Most of the medicinal plants exerted antidepressant effects through synaptic regulation of serotonin, noradrenaline, dopamine and by decreasing inflammatory mediators. The medicinal plants that are used for the treatment of depression are Crocus sativus, Ginko biloba, Melissa officinalis and Valeriana officinalis. The herbal drugs should be invented further for their numerable applications and benefits. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Jyoti; Sharma, P.; Kumar, D. A Novel Therapy for the Treatment of Depression. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 138. DOI: http://doi.org/10.35652/IGJPS.2019.92S36 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
抑郁症是一种情绪障碍,其特征是情绪持续低落,感到悲伤和失去兴趣。据世界卫生组织称,全世界有3亿人患有抑郁症。美国有1620万成年人。虽然传统的抗抑郁治疗可以帮助缓解抑郁症的症状,防止疾病复发,但由于目前治疗的缺点,如不良反应,需要补充治疗。因此,从植物中寻找具有被证实的优势和有利的利患比的抗抑郁药是值得的。许多药用植物和从这些植物中提取的药物由于其药用成分的综合作用而显示出抗抑郁的特性。大多数药用植物通过突触调节血清素、去甲肾上腺素、多巴胺和减少炎症介质发挥抗抑郁作用。用于治疗抑郁症的药用植物有藏红花、银杏、茉莉和缬草。由于其众多的应用和益处,应该进一步发明草药。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:Jyoti;沙玛,p;一种治疗抑郁症的新疗法。印度国际制药公司。科学。, 2019;9(2生理):138。DOI: http://doi.org/10.35652/IGJPS.2019.92S36。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index哥白尼,Google Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
{"title":"A Novel Therapy for the Treatment of Depression","authors":"Jyoti, Pooja Sharma, Dinesh Kumar","doi":"10.35652/igjps.2019.92s36","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s36","url":null,"abstract":"Depression is a mood disorder characterized by persistently low mood and a feeling of sadness and loss of interest. In all over the world 300 million peoples are suffered with depression to the world health organization. 16.2 million adults in the united states. Although conventional antidepressant therapy can help relieve symptoms of depression and prevent relapse of the illness, complementary therapies are required due to disadvantage of the current therapy such as adverse effects. Thus, it is worthwhile to look for antidepressant from plants with proven advantage and favorable benefit to risk ratio. A number of medicinal plants and medicine derived from these plants have shown antidepressant properties by virtue of combined effect of their medicinal constituents. Most of the medicinal plants exerted antidepressant effects through synaptic regulation of serotonin, noradrenaline, dopamine and by decreasing inflammatory mediators. The medicinal plants that are used for the treatment of depression are Crocus sativus, Ginko biloba, Melissa officinalis and Valeriana officinalis. The herbal drugs should be invented further for their numerable applications and benefits. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Jyoti; Sharma, P.; Kumar, D. A Novel Therapy for the Treatment of Depression. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 138. DOI: http://doi.org/10.35652/IGJPS.2019.92S36 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"70 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76658964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of Anti-Inflammatory and Analgesic Activity of Synthesized Substituted Isoxazole Derivatives 合成取代异恶唑衍生物的抗炎镇痛活性评价
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s16
G. Kaur, Bhavneet Singh, A. Chopra, Navpreet Kaur, Divneet Kaur
Inflammation is the body’s response to harmful stimuli, such as pathogens, damaged cells, or irritants. Inflammation is a protective attempt by the organism to remove the injurious stimuli and initiate the healing process. Inflammations are of two types: acute and chronic. The signs of acute inflammation are warmth, redness, pain, swelling and loss of function. Chronic inflammation is characterized by long lasting pain, redness and swelling. Non steroidal anti-inflammatory drugs (NSAIDS) are used to treat pain and inflammation but is often accomplished by side effects such as gastric ulceration, bleeding, and renal function suppression. The aim of this research was to synthesize substituted isoxazole derivatives and to evaluate anti-inflammatory and analgesic activity of synthesized derivatives. In the present study, the chemicals o-hydroxyacetophenone and 1H-indole-3-carbaldehyde were reacted to synthesize 2’’-[5’-(1Hindol-3-yl)isoxazole-3’-yl]phenol. For pharmacological activity, rats were randomly divided into five groups. Group I animals served as control and received vehicle (CMC 0.5% solution) intraperitoneally. Group II (Diseased controlled vehicle group) animals were injected with 0.1ml of 1% carrageenan in planter of left hind limb. Group III (Standard control group) animals were treated with standard drug Diclofenac sodium (20mg/kg) intraperitoneally. Group IV animals were treated with test drug at a dose of 100mg/kg body weight, intraperiotneally as a suspension in CMC (0.5% solution). This study suggests that the isoxazole derivatives have significant anti-inflammatory and analgesic effect compared to standard (diclofenac). © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Kaur, G.; Singh, B.; Chopra, A.; Kaur, N.; Kaur, D. Evaluation of Anti-Inflammatory and Analgesic Activity of Synthesized Substituted Isoxazole Derivatives. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 118. DOI: http://doi.org/10.35652/IGJPS.2019.92S16 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
炎症是身体对有害刺激的反应,如病原体、受损细胞或刺激物。炎症是机体消除有害刺激并启动愈合过程的一种保护性尝试。炎症有两种类型:急性和慢性。急性炎症的症状是发热、发红、疼痛、肿胀和功能丧失。慢性炎症的特征是持续的疼痛、红肿。非甾体抗炎药(NSAIDS)用于治疗疼痛和炎症,但往往伴随着胃溃疡、出血和肾功能抑制等副作用。本研究的目的是合成取代异恶唑衍生物,并评价其抗炎和镇痛活性。本研究以邻羟基苯乙酮和1h -吲哚-3-醛为原料,合成了2′-[5′-(1吲哚-3-基)异恶唑-3′-基]苯酚。药理活性方面,将大鼠随机分为5组。ⅰ组为对照,腹腔注射CMC 0.5%溶液。第二组(病鼠对照组)左后肢种植体注射1%卡拉胶0.1ml。第三组(标准对照组)采用标准药物双氯芬酸钠(20mg/kg)腹腔注射。IV组动物以试验药物100mg/kg体重作为混悬液,经肠内注射于CMC(0.5%溶液)中。本研究提示异恶唑衍生物与标准双氯芬酸相比具有显著的抗炎镇痛作用。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:Kaur, G.;辛格,b;Chopra, a;考尔:;合成取代异恶唑衍生物抗炎和镇痛活性的评价。印度国际制药公司。科学。, 2019;9(2生理):118。DOI: http://doi.org/10.35652/IGJPS.2019.92S16。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index哥白尼,Google Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
{"title":"Evaluation of Anti-Inflammatory and Analgesic Activity of Synthesized Substituted Isoxazole Derivatives","authors":"G. Kaur, Bhavneet Singh, A. Chopra, Navpreet Kaur, Divneet Kaur","doi":"10.35652/igjps.2019.92s16","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s16","url":null,"abstract":"Inflammation is the body’s response to harmful stimuli, such as pathogens, damaged cells, or irritants. Inflammation is a protective attempt by the organism to remove the injurious stimuli and initiate the healing process. Inflammations are of two types: acute and chronic. The signs of acute inflammation are warmth, redness, pain, swelling and loss of function. Chronic inflammation is characterized by long lasting pain, redness and swelling. Non steroidal anti-inflammatory drugs (NSAIDS) are used to treat pain and inflammation but is often accomplished by side effects such as gastric ulceration, bleeding, and renal function suppression. The aim of this research was to synthesize substituted isoxazole derivatives and to evaluate anti-inflammatory and analgesic activity of synthesized derivatives. In the present study, the chemicals o-hydroxyacetophenone and 1H-indole-3-carbaldehyde were reacted to synthesize 2’’-[5’-(1Hindol-3-yl)isoxazole-3’-yl]phenol. For pharmacological activity, rats were randomly divided into five groups. Group I animals served as control and received vehicle (CMC 0.5% solution) intraperitoneally. Group II (Diseased controlled vehicle group) animals were injected with 0.1ml of 1% carrageenan in planter of left hind limb. Group III (Standard control group) animals were treated with standard drug Diclofenac sodium (20mg/kg) intraperitoneally. Group IV animals were treated with test drug at a dose of 100mg/kg body weight, intraperiotneally as a suspension in CMC (0.5% solution). This study suggests that the isoxazole derivatives have significant anti-inflammatory and analgesic effect compared to standard (diclofenac). © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Kaur, G.; Singh, B.; Chopra, A.; Kaur, N.; Kaur, D. Evaluation of Anti-Inflammatory and Analgesic Activity of Synthesized Substituted Isoxazole Derivatives. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 118. DOI: http://doi.org/10.35652/IGJPS.2019.92S16 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79726399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review on Recent Trends in the Development of Gastro Retentive Floating Drug Delivery System 胃内保留漂浮给药系统的研究进展
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.9103
Seema Mahor, N. Prasad, P. Chandra
{"title":"A Review on Recent Trends in the Development of Gastro Retentive Floating Drug Delivery System","authors":"Seema Mahor, N. Prasad, P. Chandra","doi":"10.35652/igjps.2019.9103","DOIUrl":"https://doi.org/10.35652/igjps.2019.9103","url":null,"abstract":"","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82805388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Alzheimer’s Disease: Neurotransmitters Involved and the Possible New Strategies 阿尔茨海默病:涉及神经递质和可能的新策略
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.9102
S. Maratha, N. Falls, N. Vashist
Alzheimer’s Disease (AD) is the progressive neurodegenerative disorder associated with many pathophysiological conditions. The aim of present review is to understand the learning and cognitive processes and study the various parameters related to Alzheimer’s Disease. The pathophysiological mechanism of the AD has been studied and neurotransmitters used in learning process and cognitive function have been described. The main pathophysiological symptom behind AD is β-Amyloid plaque and neurofibrillary entangles. The other reasons of AD include synaptic failure, decrease in calcium regulation, inflammatory mediators, problem in insulin signaling, depletion of neurotransmitters, oxidative stress and mitochondrial dysfunction. Cholinergic system is the major system involved in the learning and cognitive behaviour. The roles of various other neurotransmitters like angiotensin, GABA, dopamine, adrenaline, serotonin, histamine, nitric oxide and nerve growth factors have also been described. The neurotransmitters like acetylcholine, adrenaline and dopamine have been found to improve cognitive behaviour while NMDA, GABA, serotonin, histamine and angiotensin have diminishing effect on memory. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Maratha, S.K.; Falls, N.; Vashist, N.; Yadav, S.; Gahlot, V. Alzheimer’s disease: neurotransmitters involved and the possible new strategies. Indo Global J. Pharm. Sci., 2019; 9(1): 512. DOI: http://doi.org/10.35652/IGJPS.2019.9102 . Indo Global Journal of Pharmaceutical Sciences, 2019; 9(1): 5-12 6 resulting in increased brain β-amyloid [3]. The discrimination of vascular dementia from AD is dependent on evidence of a cerebrovascular disorder. There are unusual less cases of pure vascular dementia without neurodegenerative changes. The autopsy of clinically diagnosed vascular dementia emphasized on the presence of pathological signs of AD. Mild cognitive impairment has been defined as the earliest forms of dementia that may partly convert into AD [4]. NEUROMODULATORS USED IN LEARNING PROCESS AND MEMORY Various Neurotransmitters, Neuromodulators and their associated receptor systems used in learning and memory processes are given below: 1. Role of Cholinergic System The decrease in cognitive ability is mostly related to a suppression of cholinergic neurotransmission. Nicotine and nicotinic agonists have been found to upgrade cognition in animals [5]. Increased contact with nicotine results in positive changes on central cholinergic neurotransmitters and memory function [6]. Acetylcholinesterase (AChE) is an enzyme that blocks the effects of acetylcholine at the neurohumoral junctions of cholinergic nerve endings [2]. Anticholinesterase agents that are capable of crossing the blood-brain barrier have shown efficacy in the treatment of AD. Biochemical investigation of the samples obtatined from the brains of AD suffering patients shows reduction in nicotinic acetylcholine recept
阿尔茨海默病(AD)是一种与许多病理生理条件相关的进行性神经退行性疾病。本综述的目的是了解阿尔茨海默病的学习和认知过程,并研究与阿尔茨海默病有关的各种参数。对AD的病理生理机制进行了研究,并描述了神经递质在学习过程和认知功能中的作用。AD的主要病理生理症状是β-淀粉样斑块和神经原纤维缠结。阿尔茨海默病的其他原因包括突触功能衰竭、钙调节功能下降、炎症介质、胰岛素信号问题、神经递质耗竭、氧化应激和线粒体功能障碍。胆碱能系统是参与学习和认知行为的主要系统。其他各种神经递质如血管紧张素、GABA、多巴胺、肾上腺素、血清素、组胺、一氧化氮和神经生长因子的作用也已被描述。神经递质如乙酰胆碱、肾上腺素和多巴胺被发现可以改善认知行为,而NMDA、GABA、血清素、组胺和血管紧张素对记忆的影响逐渐减弱。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:马拉地,S.K.;瀑布:;Vashist:;Yadav,美国;阿尔茨海默病:涉及的神经递质和可能的新策略。印度国际制药公司。科学。, 2019;9(1): 512。DOI: http://doi.org/10.35652/IGJPS.2019.9102。印度全球制药科学杂志,2019;9(1): 5-12 6导致脑β-淀粉样蛋白[3]增加。区分血管性痴呆和AD依赖于脑血管疾病的证据。没有神经退行性改变的纯血管性痴呆病例很少。临床诊断为血管性痴呆的尸检强调AD病理体征的存在。轻度认知障碍被定义为痴呆的早期形式,可能部分转化为AD。在学习和记忆过程中使用的各种神经递质、神经调节剂及其相关受体系统如下:胆碱能系统的作用认知能力的下降主要与胆碱能神经传递的抑制有关。尼古丁和尼古丁激动剂已被发现能提高动物的认知能力。增加与尼古丁的接触导致中枢胆碱能神经递质和记忆功能[6]的积极变化。乙酰胆碱酯酶(AChE)是一种阻断乙酰胆碱在胆碱能神经末梢的神经体液连接处作用的酶。能够穿过血脑屏障的抗胆碱酯酶药物已显示出治疗AD的有效性。从阿尔茨海默病患者的大脑中获得的样本的生化调查显示,烟碱乙酰胆碱受体(nAChRs)减少,丁基胆碱酯酶增强,乙酰胆碱和失活酶[7]减少。丁酰胆碱酯酶和乙酰胆碱酯酶通过水解递质从而使其失活来帮助消除乙酰胆碱酯酶。AD中最不受保护的神经元似乎是那些nachr水平升高的神经元,特别是那些含有α7亚基[8]的神经元,并且nachr的数量以及它们的一些连接蛋白在AD[9]中发生变化。α7 nachr不仅定位于斑块,而且α7和α4亚基也与积累淀粉样蛋白β (A β)[10]的神经元正校正。可以肯定的是,AD不仅涉及到脑内胆碱能神经系统神经元的损伤,还涉及到nachr的整体减少,而且AD在不同脑部位和不同细胞类型中,各种亚基的上调或下调似乎存在差异。2. 多巴胺系统的作用多巴胺是哺乳动物大脑中主要的儿茶酚胺类神经递质,控制着多种功能,包括食物摄入、运动活动、情绪、认知和内分泌管理。在AD患者的大脑皮层和杏仁核区域,多巴胺及其活性代谢物同质香草酸水平降低。多巴胺(DA)受体激动剂培高利特已被发现可以改善人类的记忆力。D2多巴胺受体拮抗剂(-)-舒必利对咖啡因[12]的记忆增强作用有拮抗作用。3.各种5-羟色胺受体在记忆过程中的生理作用及其受5-羟色胺消耗物氯苯丙氨酸(pCPA)调节的作用已在使用穿梭箱[13]的大鼠中得到证实。5-HT2拮抗剂米安色林改善慢性精神分裂症患者的认知功能。5ht3受体拮抗剂昂丹司琼改善动物模型的学习和认知行为[b]。 5-HT通过阻止NMDA受体的激活和ampa介导的电流的增加而导致LTP诱导[16],从而降低海马部分的长期增强(LTP)。突触前5-HT1A受体减少谷氨酸分泌[17]。5-HT1B受体位于水尾锥体神经元轴突末端。在5-HT1B激动剂治疗后发现记忆障碍,这可能是海马活动[18]部分回路中兴奋性神经传递减少的结果。4. gaba -能系统Muscimol(一种GABAA受体激动剂)的作用被发现,在获得试验[19]后立即给药,会损害啮齿动物的检索能力。另一方面,在训练前30分钟注射双管碱是一种gabaa拮抗剂,可以增强小鸡b[20]和大鼠[21]的记忆。巴氯芬,一种GABAB受体激动剂,通过以剂量依赖的方式激活突触前GABAB受体,从而损害大鼠的空间学习能力[22]。GABAA和GABAB受体的激活可能参与了导致记忆损伤的过程。GABAA受体在大脑中协调快速抑制作用,GABAA受体的激活引起神经元的超极化和活性降低。增强GABA作用的化合物可以损害记忆加工,而降低GABA作用的化合物可以增强记忆加工,特别是占有过程[24]。5. 组胺作为一种神经递质在中枢神经系统中起着至关重要的作用,并通过特定受体(包括H1、H2、H3和H4组胺受体[5])积极参与各种生理功能。H1、H2和H3亚型在中枢神经系统均有表达,H4亚型仅在Indo Global Journal of Pharmaceutical Sciences, 2019;9(1): 5-12 7在外周血中发现,主要见于骨髓和白细胞[25]。人们普遍认为,组胺与其他递质系统一起参与大脑的高级任务,如记忆和学习。早期的报道还显示,在组胺重复预处理期间,磺胺必利与组胺联合使用可逆转训练后组胺bbb引起的健忘症。组胺和组氨酸改善了短期记忆,逆转了MK-801诱导的空间记忆丧失,这可能是通过突触后h1受体[27]实现的。硫哌丁胺是第一种特异性h3受体拮抗剂,可改善记忆巩固,逆转东莨菪碱或二唑西平所致的认知功能障碍。注射氯苯普罗比特(每个部位5,10 ug,取决于剂量)显著改善参考记忆,重点是MK-801引发的日常记忆效应,可能是通过增加内源性组胺bbb6的释放。NMDA (n-甲基- d -天冬氨酸)激活NMDA受体的作用据报道影响学习和认知行为b[30]美金刚是一种非竞争性NMDA受体拮抗剂,已上市用于治疗AD b[30]。美金刚具有神经保护作用,可阻断β-淀粉样蛋白诱导的神经变性[31]。谷氨酸激活多种突触后受体,包括NMDA受体,该受体与记忆过程、痴呆和阿尔茨海默病的病理生理进展有关。谷氨酸受体受到刺激时,产生活性氧(ROS)并参与程序性细胞死亡系列[32]。7. 血管紧张素转换酶(ACE)的作用脑RAS在神经源性高血压[33]、脑血管体液平衡[34]和钠摄入[35]的管理中起着至关重要的作用。最新的研究表明,临床和实验证据表明,大脑RAS参与中风[36],除了其他神经系统疾病,如AD[37],帕金森病[38],血管紧张素II调节长期记忆外观,但不影响记忆储存[39]。像卡托普利和依那普利这样的ACE抑制剂已经在不同的动物记忆和学习模型中显示出改善认知能力[8]。神经生长因子的作用神经生长因子(NGF)是保护胆碱能神经元免受神经退行性变的最重要参数。神经生长因子(NGF)、脑源性神经因子(BDNF)、胶质源性神经因子(GDNF)参与神经退行性疾病的治疗。不同的神经元会依赖不同的生长因子来保护自己免受持续的损伤,例如NGF保护胆碱能系统神经元最可能的损伤[42],而对于多巴胺能神经元,BDNF[43]更有效地维持这种作用。9. 一氧化氮的作用一氧化氮自由基在脑内的
{"title":"Alzheimer’s Disease: Neurotransmitters Involved and the Possible New Strategies","authors":"S. Maratha, N. Falls, N. Vashist","doi":"10.35652/igjps.2019.9102","DOIUrl":"https://doi.org/10.35652/igjps.2019.9102","url":null,"abstract":"Alzheimer’s Disease (AD) is the progressive neurodegenerative disorder associated with many pathophysiological conditions. The aim of present review is to understand the learning and cognitive processes and study the various parameters related to Alzheimer’s Disease. The pathophysiological mechanism of the AD has been studied and neurotransmitters used in learning process and cognitive function have been described. The main pathophysiological symptom behind AD is β-Amyloid plaque and neurofibrillary entangles. The other reasons of AD include synaptic failure, decrease in calcium regulation, inflammatory mediators, problem in insulin signaling, depletion of neurotransmitters, oxidative stress and mitochondrial dysfunction. Cholinergic system is the major system involved in the learning and cognitive behaviour. The roles of various other neurotransmitters like angiotensin, GABA, dopamine, adrenaline, serotonin, histamine, nitric oxide and nerve growth factors have also been described. The neurotransmitters like acetylcholine, adrenaline and dopamine have been found to improve cognitive behaviour while NMDA, GABA, serotonin, histamine and angiotensin have diminishing effect on memory. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Maratha, S.K.; Falls, N.; Vashist, N.; Yadav, S.; Gahlot, V. Alzheimer’s disease: neurotransmitters involved and the possible new strategies. Indo Global J. Pharm. Sci., 2019; 9(1): 512. DOI: http://doi.org/10.35652/IGJPS.2019.9102 . Indo Global Journal of Pharmaceutical Sciences, 2019; 9(1): 5-12 6 resulting in increased brain β-amyloid [3]. The discrimination of vascular dementia from AD is dependent on evidence of a cerebrovascular disorder. There are unusual less cases of pure vascular dementia without neurodegenerative changes. The autopsy of clinically diagnosed vascular dementia emphasized on the presence of pathological signs of AD. Mild cognitive impairment has been defined as the earliest forms of dementia that may partly convert into AD [4]. NEUROMODULATORS USED IN LEARNING PROCESS AND MEMORY Various Neurotransmitters, Neuromodulators and their associated receptor systems used in learning and memory processes are given below: 1. Role of Cholinergic System The decrease in cognitive ability is mostly related to a suppression of cholinergic neurotransmission. Nicotine and nicotinic agonists have been found to upgrade cognition in animals [5]. Increased contact with nicotine results in positive changes on central cholinergic neurotransmitters and memory function [6]. Acetylcholinesterase (AChE) is an enzyme that blocks the effects of acetylcholine at the neurohumoral junctions of cholinergic nerve endings [2]. Anticholinesterase agents that are capable of crossing the blood-brain barrier have shown efficacy in the treatment of AD. Biochemical investigation of the samples obtatined from the brains of AD suffering patients shows reduction in nicotinic acetylcholine recept","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84527484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Herbal Medicines - An Emerging Trend in the treatment of Migraine 草药——偏头痛治疗的新趋势
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s45
S. Kaur, Pooja Sharma, Dinesh Kumar
{"title":"Herbal Medicines - An Emerging Trend in the treatment of Migraine","authors":"S. Kaur, Pooja Sharma, Dinesh Kumar","doi":"10.35652/igjps.2019.92s45","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s45","url":null,"abstract":"","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"47 24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78844777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Buccal Drug Delivery System: Novel Therapy for Diabetic Patients with Hypertension 口腔给药系统的发展:糖尿病高血压患者的新疗法
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s27
P. Chaudhary, V. Pandit
The present studies aim that development of buccal drug delivery system novel therapy for diabetic patient with hypertension. Hypertension is a major modifiable risk factor for cardiovascular morbidity and mortality in patients with diabetes. Lowering blood pressure is the main goal of treatment. A nonpharmacologic approach is recommended in all patients. If BP levels remains above the target despite nonpharmacologic treatment drug therapy should be initiated. Blockers of the rennin-angiotensin-aldosterone system (RAAS) represent the cornerstone of the antihypertensive drug arsenal; however, in most patients combination therapy is required. For many patients a combination of RAAS blocker and calcium antagonist is the combination preferred by treating physician. The buccal tablet was prepared by using Pioglitazone and Cilnidipine as a combined dosage form with other excipients such as cabopol 971 or 974, HPMC K4M, HPMC K15CPS, Sodium CMC, Glucodeoxycholate, β cyclodextrin, lactose, magnesium stearate, ethyl cellulose, ethanol, methanol and required amount of distilled water. The prepared buccal tablet was evaluated for physical appearance, hardness, friability, disintegration, bioadhesion strength, ex vivo residence time, swelling index and in vitro dissolution studies were performed. Stability study in natural saliva indicated that optimized formulation has good stability in human saliva. It was inferred that the prepared buccal tablet combined dosage form is very useful for the treatment of diabetic patient with hypertension. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Chaudhary, P.; Pandit, V. Development of Buccal Drug Delivery System: Novel Therapy for Diabetic Patients with Hypertension. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 129. DOI: http://doi.org/10.35652/IGJPS.2019.92S27 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
本研究旨在开发口腔给药系统,为糖尿病合并高血压患者提供一种新的治疗方法。高血压是糖尿病患者心血管发病率和死亡率的一个主要可改变的危险因素。降低血压是治疗的主要目标。建议所有患者采用非药物治疗。如果非药物治疗后血压水平仍高于目标,则应开始药物治疗。肾素-血管紧张素-醛固酮系统(RAAS)阻滞剂是抗高血压药物库的基石;然而,大多数患者需要联合治疗。对于许多患者,RAAS阻滞剂和钙拮抗剂的组合是治疗医生首选的组合。以吡格列酮和西尼地平为联合剂型,配以卡波波尔971或974、HPMC K4M、HPMC K15CPS、CMC钠、葡萄糖脱氧胆酸盐、β环糊精、乳糖、硬脂酸镁、纤维素乙酯、乙醇、甲醇和适量蒸馏水制备口腔片。对制备的口腔片进行了物理外观、硬度、脆性、崩解性、生物黏附强度、体外停留时间、溶胀指数和体外溶出度研究。天然唾液稳定性研究表明,优化后的制剂在人唾液中具有良好的稳定性。由此推测,所制备的含片联合剂型对糖尿病合并高血压患者的治疗是非常有效的。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:Chaudhary, P.;口腔给药系统的发展:糖尿病高血压患者的新疗法。印度国际制药公司。科学。, 2019;9(2生理):129。DOI: http://doi.org/10.35652/IGJPS.2019.92S27。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index哥白尼,Google Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
{"title":"Development of Buccal Drug Delivery System: Novel Therapy for Diabetic Patients with Hypertension","authors":"P. Chaudhary, V. Pandit","doi":"10.35652/igjps.2019.92s27","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s27","url":null,"abstract":"The present studies aim that development of buccal drug delivery system novel therapy for diabetic patient with hypertension. Hypertension is a major modifiable risk factor for cardiovascular morbidity and mortality in patients with diabetes. Lowering blood pressure is the main goal of treatment. A nonpharmacologic approach is recommended in all patients. If BP levels remains above the target despite nonpharmacologic treatment drug therapy should be initiated. Blockers of the rennin-angiotensin-aldosterone system (RAAS) represent the cornerstone of the antihypertensive drug arsenal; however, in most patients combination therapy is required. For many patients a combination of RAAS blocker and calcium antagonist is the combination preferred by treating physician. The buccal tablet was prepared by using Pioglitazone and Cilnidipine as a combined dosage form with other excipients such as cabopol 971 or 974, HPMC K4M, HPMC K15CPS, Sodium CMC, Glucodeoxycholate, β cyclodextrin, lactose, magnesium stearate, ethyl cellulose, ethanol, methanol and required amount of distilled water. The prepared buccal tablet was evaluated for physical appearance, hardness, friability, disintegration, bioadhesion strength, ex vivo residence time, swelling index and in vitro dissolution studies were performed. Stability study in natural saliva indicated that optimized formulation has good stability in human saliva. It was inferred that the prepared buccal tablet combined dosage form is very useful for the treatment of diabetic patient with hypertension. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Chaudhary, P.; Pandit, V. Development of Buccal Drug Delivery System: Novel Therapy for Diabetic Patients with Hypertension. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 129. DOI: http://doi.org/10.35652/IGJPS.2019.92S27 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"121 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84935997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aristolochia indica: A Review 马兜铃:综述
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s56
M. Marwaha, Dinesh Kumar, Pooja Sharma
{"title":"Aristolochia indica: A Review","authors":"M. Marwaha, Dinesh Kumar, Pooja Sharma","doi":"10.35652/igjps.2019.92s56","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s56","url":null,"abstract":"","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72663601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Review of Terminalia arjuna Effective in Treatment of Cardiovascular Disorder 阿朱末治疗心血管疾病的疗效综述
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.92s34
A. Sharma, Dinesh Kumar, Pooja Sharma
Cardiovascular diseases have become the leading cause of mortality in India. The epidemiological studies suggest that the ischaemia in cardiac muscle, stroke are the major causes and responsible for >80% of cardiovascular deaths. The Global Burden of disease study estimates of age standardized cardiovascular disease death rate of 272 per 10000 population in India is higher than its global average of 235 per 100000 population. Herbal medicine are also potent medicinal agents like synthetic drugs and are considered to be less toxic and having less side effect in contrast to synthetic drugs. The ultimate norm for any medicine is their specificity, stability, potency, non-toxicity, and efficacy. Terminalia arjuna is one of the most accepted and beneficial plant in indigenous system of medicine. Bark decoction of Terminalia Arjuna is used as a cardioprotective and cardiotonic in angina pectoris, poor blood circulation and for symptomatic relief in high blood pressure.The bark extract contains acids (arjunolic acid, terminic acid), glycosides (arjunetin, arjunosides 1,4) and strong antioxidants flavones, tannins, oligomeric proanthocyanodins. Both of the studies, experimental and clinical, have suggested that the crude drug possesses hypolipidemic, anti-atherogenic activities, anti-ischemic and antioxidant activity. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Sharma; A.; Kumar, D.; Sharma, P. A Review of Terminalia arjuna Effective in Treatment of Cardiovascular Disorders. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 136. DOI: http://doi.org/10.35652/IGJPS.2019.92S34 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.
心血管疾病已成为印度死亡的主要原因。流行病学研究表明,心肌缺血、中风是主要原因,占心血管死亡的80%以上。全球疾病负担研究估计,印度年龄标准化心血管疾病死亡率为每1万人中272人,高于每10万人中235人的全球平均水平。草药也是像合成药物一样的强效药物,与合成药物相比,被认为毒性更小,副作用更小。任何药物的最终标准是其特异性、稳定性、效力、无毒性和有效性。铁蒺藜是我国本土医学体系中公认的有益植物之一。阿朱那树皮煎剂对心绞痛、血液循环不畅、高血压有护心强心作用。树皮提取物含有酸(arjunolic acid, terminic acid),苷(arjunetin, arjunnosides 1,4)和强抗氧化剂黄酮,单宁,低聚原花青素。实验和临床研究均表明,该药材具有降血脂、抗动脉粥样硬化、抗缺血和抗氧化活性。©2019 igglobal研究与出版基金会。版权所有。引用本文如下:Sharma;答:;库马尔,d;arjunia终末草治疗心血管疾病的研究进展。印度国际制药公司。科学。, 2019;9(2生理):136。DOI: http://doi.org/10.35652/IGJPS.2019.92S34。印度全球药物科学杂志(ISSN 2249 1023;CODENIGJPAI;NLM ID: 101610675)在CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index哥白尼,Google Scholar等中索引和摘要。欲了解更多详情,请访问http://iglobaljournal.com这是由APTI赞助,印度旁遮普阿姆利则马纳瓦拉斯里赛药学院组织的“RAPSCON-2019”的特刊。以日志形式提供放松。
{"title":"A Review of Terminalia arjuna Effective in Treatment of Cardiovascular Disorder","authors":"A. Sharma, Dinesh Kumar, Pooja Sharma","doi":"10.35652/igjps.2019.92s34","DOIUrl":"https://doi.org/10.35652/igjps.2019.92s34","url":null,"abstract":"Cardiovascular diseases have become the leading cause of mortality in India. The epidemiological studies suggest that the ischaemia in cardiac muscle, stroke are the major causes and responsible for >80% of cardiovascular deaths. The Global Burden of disease study estimates of age standardized cardiovascular disease death rate of 272 per 10000 population in India is higher than its global average of 235 per 100000 population. Herbal medicine are also potent medicinal agents like synthetic drugs and are considered to be less toxic and having less side effect in contrast to synthetic drugs. The ultimate norm for any medicine is their specificity, stability, potency, non-toxicity, and efficacy. Terminalia arjuna is one of the most accepted and beneficial plant in indigenous system of medicine. Bark decoction of Terminalia Arjuna is used as a cardioprotective and cardiotonic in angina pectoris, poor blood circulation and for symptomatic relief in high blood pressure.The bark extract contains acids (arjunolic acid, terminic acid), glycosides (arjunetin, arjunosides 1,4) and strong antioxidants flavones, tannins, oligomeric proanthocyanodins. Both of the studies, experimental and clinical, have suggested that the crude drug possesses hypolipidemic, anti-atherogenic activities, anti-ischemic and antioxidant activity. © 2019 iGlobal Research and Publishing Foundation. All rights reserved. Cite this article as: Sharma; A.; Kumar, D.; Sharma, P. A Review of Terminalia arjuna Effective in Treatment of Cardiovascular Disorders. Indo Global J. Pharm. Sci., 2019; 9(2Suppl.): 136. DOI: http://doi.org/10.35652/IGJPS.2019.92S34 . Indo Global Journal of Pharmaceutical Sciences( ISSN 2249 1023; CODENIGJPAI; NLM ID: 101610675) indexed and abstracted in CrossRef (DOI Enabling), UGC CARE Journal List, EMBASE(Elsevier), National Library of Medicine (NLM) Catalog, ResearchGate, Publons, CAS (ACS), Index Copernicus, Google Scholar and many more. For further details, visit http://iglobaljournal.com This is a special issue as an outcome of ‘RAPSCON-2019’ sponsored by APTI and organized by Sri Sai College of Pharmacy, Manawala, Amritsar, Punjab, India. Relaxation offered in journal format.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"321 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76104633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can Food Supplements Combat Cancer: An Insight 食品补充剂能对抗癌症吗
Pub Date : 2019-01-01 DOI: 10.35652/igjps.2019.9105
Gupta A, Vashist N, Bajaj S, Gahlot V, Y. S, Maratha S, Rajput A
{"title":"Can Food Supplements Combat Cancer: An Insight","authors":"Gupta A, Vashist N, Bajaj S, Gahlot V, Y. S, Maratha S, Rajput A","doi":"10.35652/igjps.2019.9105","DOIUrl":"https://doi.org/10.35652/igjps.2019.9105","url":null,"abstract":"","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"193 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74196714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indo Global Journal of Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1